港通医疗
(301515)
| 流通市值：12.68亿 | | | 总市值：18.77亿 |
| 流通股本：6755.76万 | | | 总股本：1.00亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 272,557,561.17 | 50,485,892.96 | 721,613,692.59 | 344,363,431.23 |
| 营业总成本 | 279,999,205.95 | 62,319,573.87 | 665,991,785.18 | 342,076,025.87 |
| 其他经营收益 | | | | |
| 营业利润 | -24,617,706.44 | -1,798,921.04 | -9,203,180.37 | -15,741,358.62 |
| 利润总额 | -23,905,041.74 | -1,790,495.08 | -8,700,077.23 | -15,452,927.36 |
| 净利润 | -19,828,254.99 | -1,484,768.37 | -5,178,782.94 | -11,836,617.81 |
| 每股收益 | | | | |
| 其他综合收益 | -80,668.23 | - | -89,274.2 | -97,891.78 |
| 综合收益总额 | -19,908,923.22 | -1,484,768.37 | -5,268,057.14 | -11,934,509.59 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,807,327,725.74 | 1,761,175,680.04 | 1,786,915,281.71 | 1,822,394,268.57 |
| 非流动资产: | | | | |
| 非流动资产合计 | 282,766,874.4 | 273,075,203.16 | 277,576,617.25 | 239,027,171.98 |
| 资产总计 | 2,090,094,600.14 | 2,034,250,883.2 | 2,064,491,898.96 | 2,061,421,440.55 |
| 流动负债: | | | | |
| 流动负债合计 | 752,588,446.33 | 720,707,696.99 | 767,712,725.29 | 761,917,542.9 |
| 非流动负债: | | | | |
| 非流动负债合计 | 131,220,997.16 | 90,582,631.8 | 73,430,967.19 | 82,052,994.82 |
| 负债合计 | 883,809,443.49 | 811,290,328.79 | 841,143,692.48 | 843,970,537.72 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,208,515,643.04 | 1,225,215,902.18 | 1,224,881,659.18 | 1,218,079,122.28 |
| 股东权益合计 | 1,206,285,156.65 | 1,222,960,554.41 | 1,223,348,206.48 | 1,217,450,902.83 |
| 负债和股东权益合计 | 2,090,094,600.14 | 2,034,250,883.2 | 2,064,491,898.96 | 2,061,421,440.55 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 392,868,661.16 | 195,174,558.9 | 724,788,323.94 | 454,993,630.99 |
| 经营活动现金流出小计 | 438,095,051.54 | 216,505,034.08 | 735,883,923.67 | 537,106,298.83 |
| 经营活动产生的现金流量净额 | -45,226,390.38 | -21,330,475.18 | -11,095,599.73 | -82,112,667.84 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 464,429,566.33 | 463,502,140.51 | 329,675,272.76 | 330,359,032.53 |
| 投资活动现金流出小计 | 455,191,251.59 | 8,769,782.19 | 683,391,604.13 | 668,625,867.54 |
| 投资活动产生的现金流量净额 | 9,238,314.74 | 454,732,358.32 | -353,716,331.37 | -338,266,835.01 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 142,057,755.56 | 71,777,755.56 | 297,069,228.53 | 229,271,502.67 |
| 筹资活动现金流出小计 | 52,400,424.56 | 46,783,315.91 | 326,502,776.02 | 185,612,424.65 |
| 筹资活动产生的现金流量净额 | 89,657,331 | 24,994,439.65 | -29,433,547.49 | 43,659,078.02 |
| 汇率变动对现金及现金等价物的影响 | -19,872.84 | -10,071.67 | -13,527.27 | -6,553.19 |
| 现金及现金等价物净增加额 | 53,649,382.52 | 458,386,251.12 | -394,259,005.86 | -376,726,978.02 |
| 期末现金及现金等价物余额 | 235,262,522.16 | 639,999,390.76 | 181,613,139.64 | 199,145,167.48 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 53,649,382.52 | - | -394,259,005.86 | - |